Jilin Province Huinan Changlong Bio-pharmacy Company Limited (FRA:JIL)

Germany · Delayed Price · Currency is EUR

0.2420

-0.0020 (-0.82%)

Last updated: Aug 26, 2026, 8:01 AM CET

Market Cap	143.85M +8.5%
Revenue (ttm)	115.72M -3.1%
Net Income	28.18M +19.5%
EPS	0.05 +19.6%
Shares Out	n/a
PE Ratio	5.10
Forward PE	n/a
Dividend	0.03 (12.99%)
Ex-Dividend Date	Jun 22, 2026

Volume	n/a
Open	0.2420
Previous Close	0.2440
Day's Range	0.2420 - 0.2420
52-Week Range	0.2060 - 0.3080
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About FRA:JIL

Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People’s Republic of China. The company provides Edaravone injection, compound brain comfort capsules, haikun kidney capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine zinc gluconate tablets, and Qianlie Guihuang Tablets. It also engages in the manufacture and distribution of beverages and prepackaged food... [Read more]

Industry Pharmaceutical Preparations

Founded 1989

Employees 1,107

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol JIL

Financial Performance

In 2025, FRA:JIL's revenue was 901.87 million, an increase of 2.35% compared to the previous year's 881.16 million. Earnings were 198.88 million, an increase of 7.94%.

Financial numbers in CNY Financial Statements